Zusammenfassung
Die vulväre intraepitheliale Neoplasie (VIN) und der M. Paget sind präinvasive Erkrankungen der Vulva, die sich in vielen Aspekten unterscheiden oder überlappen. Bei gleicher Symptomatik kann auch das klinische Bild sehr ähnlich sein. Die Ätiologie für beide Erkrankungen ist nicht ganz geklärt, nur für einen Teil der VIN-Erkrankungen ist eine persistierende HPV-Infektion ursächlich. Die lokale Exzision steht für beide Veränderungen im Vordergrund, bei VIN zusätzlich die Laserverdampfung. Daneben gibt es einige experimentelle Behandlungsformen von unterschiedlicher Wirksamkeit und Verträglichkeit. VIN und M. Paget, insbesondere Letzterer, neigen stark zum Rezidiv. Daraus ergeben sich Bedeutung und Notwendigkeit einer zuverlässigen klinischen Nachsorge.
Abstract
Vulvar intraepithelial neoplasia (VIN) and vulvar Paget’s disease are preinvasive diseases of the vulva that differ in some aspects and overlap in others. With the same symptomatology, the clinical picture may be very similar, too. The etiology is not quite clear for either disease: Only the so-called usual type of VIN seems to be induced by persistent HPV infection. Local excision is the most prevalent form of therapy, along with laser vaporization for VIN. There are some experimental treatments of various effectiveness and tolerance. Both VIN and vulvar Paget’s disease have a strong tendency to recur; therefore, competent follow-up is necessary.
This is a preview of subscription content, access via your institution.





















Literatur
Beurden van M, ten Kate FW, Tjong-A-Hung SP et al (1998) Human papillomavirus DNA in multicentric vulvar intraepithelial neoplasia. Int J Gynecol Pathol 17:12–16
Brown HM, Wilkinson EJ (2002) Uroplakin-III to distinguish primary vulvar Paget disease from Paget disease secondary to urothelial carcinoma. Hum Pathol 33:545–548
Dubreuilh W (1901) Paget’s disease of the vulva. Br J Dermatol 13:407–413
Fong KL, Jones RW, Rowan DM (2008) Women’s perception of the outcome of the surgical management of vulvar intraepithelial neoplasia. J Reprod Med 53:952–954
Hatch KD, Davis JR (2008) Complete resolution of Paget disease of the vulva with imiquimod cream. J Low Genit Tract Dis 12:90–94
Joura EA, Leodolter S, Hernandez-Avila M et al (2007) Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 369:1693–1702
Judson PL, Habermann EB, Baxter NN et al (2006) Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 107:1018–1022
Kürzl R (1996) Paget’s disease. Semin Dermatol 15:60–66
Kürzl R (2006) Vulvar Paget’s disease treated with topical imiquimod: preliminary results of three cases. ISSVD XVIII world congress, Queenstown, Neu Zealand
Kürzl R (2009) Nicht maligne Hauterkrankungen der Vulva. Gynäkologe 42
Mohs FE, Blessing J (1979) Microscopically controlled surgery for extramammary Paget’s disease. Arch Dermatol 115:706–708
Nadji M, Ganjei P, Penneys NS, Morales AR (1984) Immunohistochemistry of vulvar neoplasms: A brief review. Int J Gynecol Pathol 3:41–50
Parmley TH, Woodruff JD, Julian CG (1975) Invasive vulvar Paget’s disease. Obstet Gynecol 46:341–346
Preti M, Mezzetti M, Robertson C, Sideri M (2000) Inter-observer variation in histopathological diagnosis and grading of vulvar intraepithelial neoplasia: results of an European collaborative study. BJOG 107:594–599
Preti M, Micheletti L, Massobrio M et al (2003) Vulvar paget disease: one century after first reported. J Low Genit Tract Dis 7:122–135
Preti M, Seters van M, Sideri M, Beurden van M (2005) Squamous vulvar intraepithelial neoplasia. Clin Obstet Gynecol 48:845–861
Regauer S (2006) Extramammary Paget’s disease – a proliferation of adnexal origin? Histopathology 48:723–729
Ronger Savle S, Julien V, Viallard AM et al (2004) Treatment of vulvar cutaneous extramammary Paget’s disease with topical imiquimod: report of two cases. 5th Congress of the European College for the Study of vulval diseases (ECSVD), Stockholm Sweden
Schön M, Bong AB, Drewniok C et al (2003) Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. J Natl Cancer Inst 95:1138–1149
Scurry J, Wilkinson EJ (2006) Review of terminology of precursors of vulvar squamous cell carcinoma. J Low Genit Tract Dis 10:161–169
Seters van M, Beurden van M, de Craen AJ (2005) Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol 97:645–651
Seters van M, Beurden van M, ten Kate FJ et al (2008) Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med 358:1465–1473
Sideri M, Jones RW, Heller DS et al (2007) Comment on the article. In: Srodon M, Stoler MH, Baber GB (eds) The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN). Am J Surg Pathol 2006;30:1513–1518. Am J Surg Pathol 31:1452–1454
Sideri M, Jones RW, Wilkinson EJ et al (2005) Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med 50:807–810
Srodon M, Stoler MH, Baber GB, Kurman RJ (2006) The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN). Am J Surg Pathol 30:1513–1518
Stenn KS (1988) The skin. In: Weiss L (ed) Cell and tissue biology. A textbook of histology. Urban & Schwarzenberg, Baltimore München, pp 541–572
Wang LC, Blanchard A, Jugde DE et al (2003) Successful treatment of recurrent extramammary Paget’s disease of the vulva with topical imiquimod 5% cream. J Am Acad Dermatol 49:769–771
Wilkinson EJ, Brown HM (2002) Vulvar Paget disease of urothelial origin: a report of three cases and a proposed classification of vulvar Paget disease. Hum Pathol 33:549–554
Wilkinson EJ, Kneale BL, Lynch PJ (1986) Report of the ISSVD Terminology Committee. J Reprod Med 31:973–974
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kürzl, R. Präinvasive Erkrankungen der Vulva. Gynäkologe 42, 265–274 (2009). https://doi.org/10.1007/s00129-008-2305-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00129-008-2305-7